High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC
Flavia Ballocca1, Fabrizio D'Ascenzo, Claudio Moretti
1Departement of Cardiology, Division of Internal Medicine, Città Della Salute e della Scienza. flaviabl@hotmail.it.
Insights
High-sensitive troponin assays (hs-cTn) can help identify coronary artery disease (CAD) in patients with chronic kidney disease (CKD). Peak troponin levels, particularly hs-cTnI, predict 30-day mortality in this high-risk population.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- The diagnostic accuracy of high-sensitive troponin (hs-cTn) for coronary artery disease (CAD) in patients with renal insufficiency remains unclear.
- Chronic kidney disease (CKD) complicates the interpretation of cardiac biomarkers.
- Evaluating the prognostic value of hs-cTn T and I in CKD patients is crucial.
Purpose of the Study:
- To assess the prognostic role of hs-cTn T and I in patients with CKD and chest pain.
- To determine the predictive value of hs-cTn for the presence of CAD in this population.
- To compare the performance of hs-cTnT and hs-cTnI assays.
Main Methods:
- Consecutive patients with chest pain and renal insufficiency (eGFR < 60 mL/min/1.73 m2) were enrolled.
- Baseline and interval hs-cTnT and hs-cTnI levels were measured.
- The predictive value for CAD and 30-day mortality was analyzed using area under the curve (AUC).
Main Results:
- No significant difference in clinical characteristics or outcomes between hs-cTnT and hs-cTnI assays.
- Baseline hs-cTn values did not effectively differentiate between patients with or without CAD (low AUC).
- Interval and peak hs-cTnI levels were significantly higher in patients with CAD and showed higher accuracy (AUC) compared to hs-cTnT.
- Peak troponin levels (both T and I) independently predicted all-cause death at 30 days.
Conclusions:
- Altered troponin levels in CKD patients indicate a high risk of coronary disease.
- Peak hs-cTn levels, especially hs-cTnI, are valuable predictors of 30-day adverse events in CKD patients.
- hs-cTnI demonstrates superior accuracy to hs-cTnT in this patient cohort.
Background:
Accuracy of high sensitive troponin (hs-cTn) to detect coronary artery disease (CAD) in patients with renal insufficiency is not established. The aim of this study was to evaluate the prognostic role of hs-cTn T and I in patients with chronic kidney disease (CKD).
Methods:
All consecutive patients with chest pain, renal insufficiency (eGFR < 60 mL/min/1.73 m2) and high sensitive troponin level were included. The predictive value of baseline and interval troponin (hs-cTnT and hs-cTnI) for the presence of CAD was assessed.
Results:
One hundred and thirteen patients with troponin I and 534 with troponin T were included, with 95 (84%) and 463 (87%) diagnosis of CAD respectively. There were no differences in clinical, procedural and outcomes between the two assays. For both, baseline hs-cTn values did not differ be-tween patients with/without CAD showing low area under the curve (AUC). For interval levels, hs-cTnI was significantly higher for patients with CAD (0.2 ± 0.8 vs. 8.9 ± 4.6 ng/mL; p = 0.04) and AUC was more accurate for troponin I than hs-cTnT (AUC 0.85 vs. 0.69). Peak level was greater for hs-cTnI in patients with CAD or thrombus (0.4 ± 0.6 vs. 15 ± 20 ng/mL; p = 0.02; AUC 0.87: 0.79-0.93); no differences were found for troponin T assays (0.8 ± 1.5 vs. 2.2 ± 3.6 ng/mL; p = 1.7), with lower AUC (0.73: 0.69-0.77). Peak troponin levels (both T and I) independently predicted all cause death at 30 days.
Conclusions:
Patients with CKD presenting with altered troponin are at high risk of coronary disease. Peak level of both troponin assays predicts events at 30 days, with troponin I being more accurate than troponin T. (Cardiol J 2017; 24, 2: 139-150).
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
03:19Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
